🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted action to address cost of living pressures" in next month's Budget.

In comments to media outlets, she emphasized that reducing inflation is a collective responsibility of both the government and the central bank.

The UK's price growth is forecast to be the most elevated among the Group of Seven advanced economies this year and next.

Possible Energy Cost Measures

Sources suggest the administration could intervene to reduce utility costs, such as by slashing the current 5% rate of VAT charged on energy.

A further option is to cut some of the government charges currently added to bills.

Fiscal Constraints and Analyst Expectations

The government will receive the next draft from the official forecaster, the OBR, on Monday, which will reveal how much room there is for such measures.

The view from the majority of analysts is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her declared debt limits.

Earlier on the same day, estimates suggested there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of expectations.

"There's a joint job between the Bank of England and the administration to further reduce some of the causes of price increases," Reeves told reporters in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Commitments and Global Issues

While much of the focus has been on likely tax rises, the chancellor said the most recent figures from the OBR had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with increasing geopolitical and commercial tensions for the Budget tax moves, probably to be directed on those "most able to pay."

Global Trade Tensions

Addressing apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests invariably are paramount."

Last week's announcement by Chinese authorities to tighten export controls on critical minerals and other resources that are crucial for advanced tech production led US President Donald Trump to propose an further 100% tariff on imports from the Asian country, increasing the risk of an all-out trade war between the two economic giants.

The US Treasury Secretary described China's decision "economic coercion" and "a international production power grab."

Asked about considering the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and limit trade."

She said the action was "damaging for the international commerce and causes further headwinds."

"I believe there are fields where we should address China, but there are also important prospects to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that balance appropriate."

The chancellor also stated she was collaborating with international partners "regarding our own critical minerals approach, so that we are less reliant."

NHS Medicine Costs and Investment

Reeves also admitted that the cost the National Health Service pays for pharmaceuticals could increase as a result of ongoing discussions with the Trump administration and its drugs companies, in return for lower tariffs and capital.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling projects in the United Kingdom, with several attributing the modest returns they are obtaining.

Last month, the government science advisor said the price the NHS spends on drugs would have to increase to stop firms and drug research funding departing from the UK.

The Chancellor stated to the BBC: "We have seen because of the cost structure, that drug testing, innovative medicines have not been provided in the UK in the manner that they are in other European countries."

"The objective is to make sure that people getting care from the NHS are able to access the best essential medicines in the globe. And so we are examining all of that, and... looking to secure more capital into Britain."